HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy

Several clinical trials have shown that oncolytic herpes simplex virus type 1 (oHSV-1) can be safely administered to patients. However, virus replication in tumor tissue has generally not been monitored in these oHSV clinical trials, and the data suggest that its oncolytic potency needs to be improv...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Li, H, Nakashima, H, Decklever, T D, Nace, R A, Russell, S J
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2013
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3747331/
https://ncbi.nlm.nih.gov/pubmed/23868101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2013.43
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars